Novel mutations associated with inherited human calcium-sensing receptor disorders: a clinical genetic study.

Clicks: 462
ID: 772
2018
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #1 of 102 articles by views in european journal of endocrinology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Molecular diagnosis is a useful diagnostic tool in calcium metabolism disorders. The calcium-sensing receptor (CaSR) is known to play a central role in the regulation of extracellular calcium homeostasis. We performed clinical, biochemical and genetic characterization of sequence anomalies in this receptor in a cohort of 130 individuals from 82 families with suspected alterations in the CASR gene, one of the largest series described.The CASR gene was screened for mutations by polymerase chain reaction followed by direct Sanger sequencing.Presumed CaSR-inactivating mutations were found in 65 patients from 26 families. These patients had hypercalcemia (median 11.3 mg/dL) but normal or abnormally high parathyroid hormone (PTH) levels (median 52 pg/mL). On the other hand, presumed CaSR-activating mutations were detected in 17 patients from 8 families. These patients had a median serum calcium level of 7.4 mg/dL and hypoparathyroidism (median PTH 13 pg/mL). Further, common polymorphisms previously associated with high blood ionized calcium levels were found in 27 patients (median calcium 10.6 mg/dL; median PTH 65 pg/mL) with no other alterations in CASR. Overall, we found 30 different mutations, of which, 14 have not been previously reported (p.Ala26Ser, p.Cys60Arg, p.Lys119Ile, p.Leu123Met, p.Glu133Val, p.Gly222Glu, p.Phe351Ile, p.Cys542Tyr, p.Cys546Gly, p.Cys677Tyr, p.Ile816Val, p.Ala887Asp, p.Glu934*, p.Pro935_Gln945dup).Patients with CASR mutations may not fit the classic clinical pictures of hypercalcemia with hypocalciuria or hypocalcemia with hypercalciuria. Molecular studies are important for confirming the diagnosis and distinguishing it from other entities. Our genetic analysis confirmed CaSR disorders in 82 patients in the study cohort.
Reference Key
garcía2018novel Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors García, Alejandro;Madariaga, Leire;Pérez de Nanclares, Gustavo;Ariceta, Gema;Gaztambide, Sonia;Group, Spanish Endocrinology;Group, Renaltube;Castaño, Luis;
Journal european journal of endocrinology
Year 2018
DOI
10.1530/EJE-18-0129
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.